compound
Mazdutide (10mg Vial) Questions Answered
Mazdutide (IBI362) is a long‑acting dual GLP‑1/glucagon receptor agonist developed for chronic weight management and type 2 diabetes.
Educational reference only. TNHL does not diagnose, prescribe, or replace care from a licensed professional. Confirm all dosing, contraindications, and product decisions with qualified guidance.
Mazdutide (10mg Vial)
Week Weekly Dose Units (per injection) (mL) Weeks 1–4 2.5 mg (2,500 mcg) 75 units (0.75 mL) Weeks 5–8+ 5 mg (5,000 mcg) 150 units (1.50 mL) Frequency: Inject once weekly subcutaneously.
Mazdutide (IBI362) is a long‑acting dual GLP‑1/glucagon receptor agonist developed for chronic weight management and type 2 diabetes.
Week Weekly Dose Units (per injection) (mL) Weeks 1–4 2.5 mg (2,500 mcg) 75 units (0.75 mL) Weeks 5–8+ 5 mg (5,000 mcg) 150 units (1.50 mL) Frequency: Inject once weekly subcutaneously.
Plan based on an 8–16 week weekly protocol with gradual titration to 5 mg maintenance.